6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05691114
(ClinicalTrials.gov)		February 202310/1/2023Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's DiseasePrecise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's DiseaseIdiopathic Parkinson's DiseaseBiological: hAESCsShanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruiting40 Years70 YearsAll18Phase 1China
2NCT05435755
(ClinicalTrials.gov)		December 2, 202215/3/2022Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.The Precise Transplantation of Human Amniotic Epithelial Stem Cells Into the Ventricle Through Surgical Robot in the Treatment of Parkinson's Disease.Parkinson's DiseaseBiological: hAESCs treatment;Biological: placebo (saline)Shanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaNot yet recruiting30 Years70 YearsAll12Early Phase 1China